Skip to main content

Peer Review reports

From: Primary cold atmospheric plasma combined with low dose cisplatin as a possible adjuvant combination therapy for HNSCC cells—an in-vitro study

Original Submission
2 Mar 2022 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
1 Apr 2022 Reviewed Reviewer Report
11 Apr 2022 Reviewed Reviewer Report - Anthony F. Markus
16 Apr 2022 Reviewed Reviewer Report
2 May 2022 Author responded Author comments - Teresa Brunner
Resubmission - Version 3
2 May 2022 Submitted Manuscript version 3
4 May 2022 Reviewed Reviewer Report - Anthony F. Markus
9 May 2022 Reviewed Reviewer Report
16 May 2022 Reviewed Reviewer Report
22 May 2022 Author responded Author comments - Teresa Brunner
Resubmission - Version 4
22 May 2022 Submitted Manuscript version 4
Publishing
23 May 2022 Editorially accepted
29 Jun 2022 Article published 10.1186/s13005-022-00322-5

You can find further information about peer review here.

Back to article page